Ophthalmologic Drug Guide

Ophthalmologic Drug Guide
-0 %
Print on Demand | Lieferzeit: Print on Demand - Lieferbar innerhalb von 3-5 Werktagen I

Unser bisheriger Preis:ORGPRICE: 74,89 €

Jetzt 53,48 €*

Alle Preise inkl. MwSt. | Versandkostenfrei
Artikel-Nr:
9781441976208
Veröffentl:
2010
Erscheinungsdatum:
03.12.2010
Seiten:
138
Autor:
Douglas J Rhee
Gewicht:
195 g
Format:
204x128x13 mm
Sprache:
Englisch
Beschreibung:

Douglas J. Rhee, MDAssistant ProfessorHarvard Medical SchoolAssociate Chief, Practice DevelopmentMassachusetts Eye & Ear InfirmaryBoston, Massachusetts USA Katheryn A. Colby, MD, PhDAssistant Professor Harvard Medical SchoolCornea ServiceMassachusetts Eye & Ear InfirmaryBoston, Massachusetts USA Christopher J. Rapuano, MDProfessorJefferson Medical CollegeDirector, Cornea ServiceWills Eye HospitalPhiladelphia, Pennsylvania USA Lucia Sobrin, MD, MPHAssistant ProfessorHarvard Medical SchoolMassachusetts Eye & Ear InfirmaryBoston, Massachusetts USA
Drug therapy as an alternative to surgical intervention is becoming increasingly common. In the past five years, new anti-glaucoma agents have becoming increasingly effective. This edition will include new information on off-label prescribing and cap colors where they are mandated by the FDA (pink/white for steroid drops, grey for topical NSAIDS, etc.);There are now several new pharmaceutical agents being used to treat retinal diseases such as age-related macular degeneration  (Macugen, Lucentis, Visudyne), while other drugs formerly prescribed have now been shown to be less effective. Intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry eye markets continue to grow, with a new formulation of Allergan's Acular 0.5% (ketorolac tromethamine) and Elestat ophthalmic solution, its new antihistamine-mast cell stabilizer.
The updated second edition of this popular pocket guide includes newly available and FDA-approved drugs as well as guidance on using the growing number of drugs now prescribed for off-label purposes, such as anti-VEGF agents used in cancer treatments.
to follow
Antibacterial Agents.- Antifungal Agents.- Antiviral Agents.- Antiparasitic Agents.- Antiglaucoma Agents.- Neuro-ophthalmology.- Retina.- Antiinflammatory Agents.- Mydriatics, Cycloplegics, and Reversal Agents.- Lubricants and Viscoelastics.- Miscellaneous (Appendices) Topical Antibacterial Spectrum.- Preparing Fortified Topical Antibiotics and Oral Acetazolamide Solution.- Antifungal Activity Spectrum.- Renal Dosing for Selected Drugs.- Glaucoma Medication Preservatives.- Product Index.- Subject Index.

Kunden Rezensionen

Zu diesem Artikel ist noch keine Rezension vorhanden.
Helfen sie anderen Besuchern und verfassen Sie selbst eine Rezension.